Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Jordan

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Gut Microbes|July 2, 2025
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomesPriyanka Biswas, Julia Sanchez-Garrido, Zuzanna Kozik, et al.
Journal of the Neurological Sciences|June 30, 2015
Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J miceBlythe C Dillingham, Margaret E Benny Klimek, Ramkishore Gernapudi, et al.
Journal of Visualized Experiments : Jove|April 28, 2017
Induction of Mesenchymal-Epithelial Transitions in Sarcoma CellsKathryn E Ware, Shivee Gilja, Shenghan Xu, et al.
Disease Models & Mechanisms|January 30, 2023
A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane proteinSabrina Yahiya, Charlie N Saunders, Sarah Hassan, et al.
The Lancet. Oncology|January 19, 2010
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)John M S Bartlett, Alison F Munro, Janet A Dunn, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Gut Microbes|July 2, 2025
The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomesPriyanka Biswas, Julia Sanchez-Garrido, Zuzanna Kozik, et al.
Journal of the Neurological Sciences|June 30, 2015
Inhibition of inflammation with celastrol fails to improve muscle function in dysferlin-deficient A/J miceBlythe C Dillingham, Margaret E Benny Klimek, Ramkishore Gernapudi, et al.
Journal of Visualized Experiments : Jove|April 28, 2017
Induction of Mesenchymal-Epithelial Transitions in Sarcoma CellsKathryn E Ware, Shivee Gilja, Shenghan Xu, et al.
Disease Models & Mechanisms|January 30, 2023
A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane proteinSabrina Yahiya, Charlie N Saunders, Sarah Hassan, et al.
The Lancet. Oncology|January 19, 2010
Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)John M S Bartlett, Alison F Munro, Janet A Dunn, et al.
EMBO Molecular Medicine|September 10, 2013
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effectsChristopher R Heier, Jesse M Damsker, Qing Yu, et al.
Pageof 3